Freenome launches SimpleScreen Lung test with target, includes blood-based CRC screening
Freenome today announced the commercial launch of its SimpleScreen Lung blood test for eligible adults, following earlier FDA approval, enabling doctors to screen for lung and colorectal cancer via single blood draw.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed